Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis

Conditions:   Breast Cancer;   HER2-positive Breast Cancer Interventions:   Drug: Pyrotinib Plus And;   Drug: Trastuzumab;   Drug: Abraxane Sponsor:   Shandong Cancer Hospital and Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials